Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,859Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4A. Menarini

02 2Melinta Therapeutics

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Delafloxacin Meglumine

Brand Name : Quofenix

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 300MG

Packaging :

Approval Date : 25-06-2021

Application Number : 1191393001

Regulatory Info : Authorized

Registration Country : Spain

blank

02

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Delafloxacin Meglumine

Brand Name : Quofenix

Dosage Form : Tablet

Dosage Strength : 450MG

Packaging :

Approval Date : 25-06-2021

Application Number : 1191393002

Regulatory Info : Authorized

Registration Country : Spain

blank

03

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Delafloxacin Meglumin

Brand Name : Quofenix

Dosage Form : Powder For Concentrate For Solution For Infusion

Dosage Strength : 300mg

Packaging :

Approval Date : 16-12-2019

Application Number : 28106090418

Regulatory Info : Prescription

Registration Country : Denmark

blank

04

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

Delafloxacin Meglumin

Brand Name : Quofenix

Dosage Form : Tablet

Dosage Strength : 450mg

Packaging :

Approval Date : 16-12-2019

Application Number : 28106090518

Regulatory Info : Prescription

Registration Country : Denmark

blank

05

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

DELAFLOXACIN MEGLUMINE

Brand Name : BAXDELA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 450MG BASE

Packaging :

Approval Date : 2017-06-19

Application Number : 208610

Regulatory Info : RX

Registration Country : USA

blank

06

ASPEN
Not Confirmed
arrow
arrow
ASPEN
Not Confirmed

DELAFLOXACIN MEGLUMINE

Brand Name : BAXDELA

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 300MG BASE/VIAL

Packaging :

Approval Date : 2017-06-19

Application Number : 208611

Regulatory Info : RX

Registration Country : USA

blank